Bundamedik Tbk PT
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, medical tourism, and dental clinic services management consulting businesses. It al… Read more
Bundamedik Tbk PT (BMHS) - Total Liabilities
Latest total liabilities as of September 2025: Rp1.48 Trillion IDR
Based on the latest financial reports, Bundamedik Tbk PT (BMHS) has total liabilities worth Rp1.48 Trillion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bundamedik Tbk PT - Total Liabilities Trend (2018–2024)
This chart illustrates how Bundamedik Tbk PT's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bundamedik Tbk PT Competitors by Total Liabilities
The table below lists competitors of Bundamedik Tbk PT ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jorjin Technologies
TWO:4980
|
Taiwan | NT$84.17 Million |
|
Claranova SE
PA:CLA
|
France | €96.30 Million |
|
Nahar Industrial Enterprises Limited
NSE:NAHARINDUS
|
India | ₹6.90 Billion |
|
Ledlink Optics
TWO:5230
|
Taiwan | NT$1.02 Billion |
|
Northumberland Bancorp
PINK:NUBC
|
USA | $634.84 Million |
|
Willow Lane Acquisition Corp. Warrants
NASDAQ:WLACW
|
USA | $4.52 Million |
|
Raven Property Group Limited
F:R4M
|
Germany | €1.04 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Bundamedik Tbk PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.86 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bundamedik Tbk PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bundamedik Tbk PT (2018–2024)
The table below shows the annual total liabilities of Bundamedik Tbk PT from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp1.30 Trillion | +1.21% |
| 2023-12-31 | Rp1.28 Trillion | +13.51% |
| 2022-12-31 | Rp1.13 Trillion | +12.94% |
| 2021-12-31 | Rp1.00 Trillion | -10.06% |
| 2020-12-31 | Rp1.11 Trillion | +51.37% |
| 2019-12-31 | Rp735.16 Billion | +3.70% |
| 2018-12-31 | Rp708.92 Billion | -- |